APO Research

APO RESEARCH · REPORT

Eszopiclone

Selected research

Industry Growth & Trends

Global Eszopiclone Industry Growth and Trends Forecast to 2032

Market perspective

The global Eszopiclone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Eszopiclone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Eszopiclone is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Eszopiclone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Eszopiclone include Tasly Pharmaceutical, Sun Pharmaceutical, Kanghong Pharmaceutical, Wockhardt, Tapi Teva, Shanghai Pharmaceuticals Holding, Kanghong Pharmaceutical, Glenmark Life Sciences and Dr. Reddy’s Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Eszopiclone market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Eszopiclone market size, estimates, and forecasts are presented in terms of sales volume (tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Eszopiclone market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Eszopiclone.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Eszopiclone market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Eszopiclone Market by Company

Tasly Pharmaceutical

Sun Pharmaceutical

Kanghong Pharmaceutical

Wockhardt

Tapi Teva

Shanghai Pharmaceuticals Holding

Kanghong Pharmaceutical

Glenmark Life Sciences

Dr. Reddy’s Laboratories

Centaur Pharmaceuticals

Admiron Life

Eszopiclone Segment by Type

Purity Above 98%

Purity Below 98%

Eszopiclone Segment by Application

Tablet

Capsule

Other

Eszopiclone Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Eszopiclone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Eszopiclone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Eszopiclone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Eszopiclone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Eszopiclone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Purity Above 98% Table 2. Major Company of Purity Below 98% Table 3. Global Eszopiclone Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Eszopiclone Sales by Type (2021-2026) & (tons) Table 5. Global Eszopiclone Sales Market Share in Volume by Type (2021-2026) Table 6. Global Eszopiclone Sales by Type (2021-2026) & (US$ Million) Table 7. Global Eszopiclone Sales Market Share in Value by Type (2021-2026) Table 8. Global Eszopiclone Price by Type (2021-2026) & (US$/kg) Table 9. Global Eszopiclone Sales by Type (2027-2032) & (tons) Table 10. Global Eszopiclone Sales Market Share in Volume by Type (2027-2032) Table 11. Global Eszopiclone Sales by Type (2027-2032) & (US$ Million) Table 12. Global Eszopiclone Sales Market Share in Value by Type (2027-2032) Table 13. Global Eszopiclone Price by Type (2027-2032) & (US$/kg) Table 14. North America Eszopiclone Sales by Type (2021-2026) & (tons) Table 15. North America Eszopiclone Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Eszopiclone Sales by Type (2021-2026) & (tons) Table 17. Europe Eszopiclone Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Eszopiclone Sales by Type (2021-2026) & (tons) Table 19. Asia-Pacific Eszopiclone Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Eszopiclone Sales by Type (2021-2026) & (tons) Table 21. Latin America Eszopiclone Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Eszopiclone Sales by Type (2021-2026) & (tons) Table 23. Middle East and Africa Eszopiclone Sales by Type (2021-2026) & (US$ Million) Table 24. Eszopiclone Industry Trends Table 25. Eszopiclone Industry Drivers Table 26. Eszopiclone Industry Opportunities and Challenges Table 27. Eszopiclone Industry Restraints Table 28. Global Eszopiclone Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Eszopiclone Revenue Market Share by Company (2021-2026) Table 30. Global Eszopiclone Sales by Company (2021-2026) & (tons) Table 31. Global Eszopiclone Sales Share by Company (2021-2026) Table 32. Global Eszopiclone Market Price by Company (2021-2026) & (US$/kg) Table 33. Global Eszopiclone Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Eszopiclone Major Company Production Sites and Headquarters Table 35. Global Eszopiclone Company, Product Type & Application Table 36. Global Eszopiclone Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Eszopiclone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Eszopiclone Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Eszopiclone Sales by Region (2021-2026) & (tons) Table 41. Global Eszopiclone Sales Market Share in Volume by Region (2021-2026) Table 42. Global Eszopiclone Sales by Region (2021-2026) & (US$ Million) Table 43. Global Eszopiclone Sales Market Share in Value by Region (2021-2026) Table 44. Global Eszopiclone Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 45. Global Eszopiclone Sales by Region (2027-2032) & (tons) Table 46. Global Eszopiclone Sales Market Share in Volume by Region (2027-2032) Table 47. Global Eszopiclone Sales by Region (2027-2032) & (US$ Million) Table 48. Global Eszopiclone Sales Market Share in Value by Region (2027-2032) Table 49. Global Eszopiclone Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2027-2032) Table 50. Global Eszopiclone Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Eszopiclone Sales by Application (2021-2026) & (tons) Table 52. Global Eszopiclone Sales Market Share in Volume by Application (2021-2026) Table 53. Global Eszopiclone Sales by Application (2021-2026) & (US$ Million) Table 54. Global Eszopiclone Sales Market Share in Value by Application (2021-2026) Table 55. Global Eszopiclone Price by Application (2021-2026) & (US$/kg) Table 56. Global Eszopiclone Sales by Application (2027-2032) & (tons) Table 57. Global Eszopiclone Sales Market Share in Volume by Application (2027-2032) Table 58. Global Eszopiclone Sales by Application (2027-2032) & (US$ Million) Table 59. Global Eszopiclone Sales Market Share in Value by Application (2027-2032) Table 60. Global Eszopiclone Price by Application (2027-2032) & (US$/kg) Table 61. North America Eszopiclone Sales by Application (2021-2026) & (tons) Table 62. North America Eszopiclone Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Eszopiclone Sales by Application (2021-2026) & (tons) Table 64. Europe Eszopiclone Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Eszopiclone Sales by Application (2021-2026) & (tons) Table 66. Asia-Pacific Eszopiclone Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Eszopiclone Sales by Application (2021-2026) & (tons) Table 68. Latin America Eszopiclone Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Eszopiclone Sales by Application (2021-2026) & (tons) Table 70. Middle East and Africa Eszopiclone Sales by Application (2021-2026) & (US$ Million) Table 71. Tasly Pharmaceutical Company Information Table 72. Tasly Pharmaceutical Business Overview Table 73. Tasly Pharmaceutical Eszopiclone Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 74. Tasly Pharmaceutical Eszopiclone Product Portfolio Table 75. Tasly Pharmaceutical Recent Development Table 76. Sun Pharmaceutical Company Information Table 77. Sun Pharmaceutical Business Overview Table 78. Sun Pharmaceutical Eszopiclone Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 79. Sun Pharmaceutical Eszopiclone Product Portfolio Table 80. Sun Pharmaceutical Recent Development Table 81. Kanghong Pharmaceutical Company Information Table 82. Kanghong Pharmaceutical Business Overview Table 83. Kanghong Pharmaceutical Eszopiclone Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 84. Kanghong Pharmaceutical Eszopiclone Product Portfolio Table 85. Kanghong Pharmaceutical Recent Development Table 86. Wockhardt Company Information Table 87. Wockhardt Business Overview Table 88. Wockhardt Eszopiclone Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 89. Wockhardt Eszopiclone Product Portfolio Table 90. Wockhardt Recent Development Table 91. Tapi Teva Company Information Table 92. Tapi Teva Business Overview Table 93. Tapi Teva Eszopiclone Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 94. Tapi Teva Eszopiclone Product Portfolio Table 95. Tapi Teva Recent Development Table 96. Shanghai Pharmaceuticals Holding Company Information Table 97. Shanghai Pharmaceuticals Holding Business Overview Table 98. Shanghai Pharmaceuticals Holding Eszopiclone Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 99. Shanghai Pharmaceuticals Holding Eszopiclone Product Portfolio Table 100. Shanghai Pharmaceuticals Holding Recent Development Table 101. Kanghong Pharmaceutical Company Information Table 102. Kanghong Pharmaceutical Business Overview Table 103. Kanghong Pharmaceutical Eszopiclone Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 104. Kanghong Pharmaceutical Eszopiclone Product Portfolio Table 105. Kanghong Pharmaceutical Recent Development Table 106. Glenmark Life Sciences Company Information Table 107. Glenmark Life Sciences Business Overview Table 108. Glenmark Life Sciences Eszopiclone Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 109. Glenmark Life Sciences Eszopiclone Product Portfolio Table 110. Glenmark Life Sciences Recent Development Table 111. Dr. Reddy’s Laboratories Company Information Table 112. Dr. Reddy’s Laboratories Business Overview Table 113. Dr. Reddy’s Laboratories Eszopiclone Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 114. Dr. Reddy’s Laboratories Eszopiclone Product Portfolio Table 115. Dr. Reddy’s Laboratories Recent Development Table 116. Centaur Pharmaceuticals Company Information Table 117. Centaur Pharmaceuticals Business Overview Table 118. Centaur Pharmaceuticals Eszopiclone Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 119. Centaur Pharmaceuticals Eszopiclone Product Portfolio Table 120. Centaur Pharmaceuticals Recent Development Table 121. Admiron Life Company Information Table 122. Admiron Life Business Overview Table 123. Admiron Life Eszopiclone Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 124. Admiron Life Eszopiclone Product Portfolio Table 125. Admiron Life Recent Development Table 126. North America Eszopiclone Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 127. North America Eszopiclone Sales by Country (2021-2026) & (tons) Table 128. North America Eszopiclone Sales Market Share by Country (2021-2026) Table 129. North America Eszopiclone Sales Forecast by Country (2027-2032) & (tons) Table 130. North America Eszopiclone Sales Market Share Forecast by Country (2027-2032) Table 131. North America Eszopiclone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Eszopiclone Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Eszopiclone Market Share by Country (2021-2026) Table 134. North America Eszopiclone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Eszopiclone Market Share Forecast by Country (2027-2032) Table 136. Europe Eszopiclone Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 137. Europe Eszopiclone Sales by Country (2021-2026) & (tons) Table 138. Europe Eszopiclone Sales Market Share by Country (2021-2026) Table 139. Europe Eszopiclone Sales Forecast by Country (2027-2032) & (tons) Table 140. Europe Eszopiclone Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Eszopiclone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Eszopiclone Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Eszopiclone Market Share by Country (2021-2026) Table 144. Europe Eszopiclone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Eszopiclone Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Eszopiclone Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Eszopiclone Sales by Country (2021-2026) & (tons) Table 148. Asia-Pacific Eszopiclone Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Eszopiclone Sales Forecast by Country (2027-2032) & (tons) Table 150. Asia-Pacific Eszopiclone Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Eszopiclone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Eszopiclone Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Eszopiclone Market Share by Country (2021-2026) Table 154. Asia-Pacific Eszopiclone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Eszopiclone Market Share Forecast by Country (2027-2032) Table 156. Latin America Eszopiclone Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 157. Latin America Eszopiclone Sales by Country (2021-2026) & (tons) Table 158. Latin America Eszopiclone Sales Market Share by Country (2021-2026) Table 159. Latin America Eszopiclone Sales Forecast by Country (2027-2032) & (tons) Table 160. Latin America Eszopiclone Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Eszopiclone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Eszopiclone Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Eszopiclone Market Share by Country (2021-2026) Table 164. Latin America Eszopiclone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Eszopiclone Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Eszopiclone Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Eszopiclone Sales by Country (2021-2026) & (tons) Table 168. Middle East and Africa Eszopiclone Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Eszopiclone Sales Forecast by Country (2027-2032) & (tons) Table 170. Middle East and Africa Eszopiclone Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Eszopiclone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Eszopiclone Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Eszopiclone Market Share by Country (2021-2026) Table 174. Middle East and Africa Eszopiclone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Eszopiclone Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Eszopiclone Distributors List Table 179. Eszopiclone Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Eszopiclone Image Figure 2. Global Eszopiclone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Eszopiclone Market Size (2021-2032) & (US$ Million) Figure 4. Global Eszopiclone Sales (2021-2032) & (tons) Figure 5. Purity Above 98% Image Figure 6. Global Purity Above 98% Sales YoY Growth (2021-2032) & (tons) Figure 7. Purity Below 98% Image Figure 8. Global Purity Below 98% Sales YoY Growth (2021-2032) & (tons) Figure 9. Global Eszopiclone Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Eszopiclone Market Share by Type 2025 VS 2032 Figure 11. North America Eszopiclone Sales Market Share in Volume by Type in 2025 Figure 12. North America Eszopiclone Sales Market Share in Value by Type in 2025 Figure 13. Europe Eszopiclone Sales Market Share in Volume by Type in 2025 Figure 14. Europe Eszopiclone Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Eszopiclone Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Eszopiclone Sales Market Share in Value by Type in 2025 Figure 17. Latin America Eszopiclone Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Eszopiclone Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Eszopiclone Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Eszopiclone Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Eszopiclone Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Tablet Image Figure 24. Global Tablet Sales YoY Growth (2021-2032) & (tons) Figure 25. Capsule Image Figure 26. Global Capsule Sales YoY Growth (2021-2032) & (tons) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (tons) Figure 29. Global Eszopiclone Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Eszopiclone Market Share by Application 2025 VS 2032 Figure 31. North America Eszopiclone Sales Market Share in Volume by Application in 2025 Figure 32. North America Eszopiclone Sales Market Share in Value by Application in 2025 Figure 33. Europe Eszopiclone Sales Market Share in Volume by Application in 2025 Figure 34. Europe Eszopiclone Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Eszopiclone Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Eszopiclone Sales Market Share in Value by Application in 2025 Figure 37. Latin America Eszopiclone Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Eszopiclone Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Eszopiclone Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Eszopiclone Sales Market Share in Value by Application in 2025 Figure 41. North America Eszopiclone Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 42. North America Eszopiclone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Eszopiclone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Eszopiclone Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Eszopiclone Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 46. Europe Eszopiclone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Eszopiclone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Eszopiclone Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Eszopiclone Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 50. Asia-Pacific Eszopiclone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Eszopiclone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Eszopiclone Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Eszopiclone Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 54. Latin America Eszopiclone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Eszopiclone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Eszopiclone Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Eszopiclone Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 58. Middle East and Africa Eszopiclone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Eszopiclone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Eszopiclone Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Eszopiclone Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Eszopiclone Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Purity Above 98%
  • Purity Below 98%
Applications
  • Tablet
  • Capsule
  • Other
Companies covered
  • Tasly Pharmaceutical
  • Sun Pharmaceutical
  • Kanghong Pharmaceutical
  • Wockhardt
  • Tapi Teva
  • Shanghai Pharmaceuticals Holding
  • Kanghong Pharmaceutical
  • Glenmark Life Sciences
  • Dr. Reddy’s Laboratories
  • Centaur Pharmaceuticals
  • Admiron Life

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Eszopiclone Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Eszopiclone Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Eszopiclone Market by Type
  6. 1.3.1 Purity Above 98%
  7. 1.3.2 Purity Below 98%
  8. 1.4 Global Eszopiclone Market Size by Type
  9. 1.4.1 Global Eszopiclone Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Eszopiclone Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Eszopiclone Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Eszopiclone Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Eszopiclone Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Eszopiclone Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Eszopiclone Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Eszopiclone Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Eszopiclone Industry Trends
  2. 2.2 Eszopiclone Industry Drivers
  3. 2.3 Eszopiclone Industry Opportunities and Challenges
  4. 2.4 Eszopiclone Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Eszopiclone Revenue (2021-2026)
  2. 3.2 Global Top Players by Eszopiclone Sales (2021-2026)
  3. 3.3 Global Top Players by Eszopiclone Price (2021-2026)
  4. 3.4 Global Eszopiclone Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Eszopiclone Major Company Production Sites & Headquarters
  6. 3.6 Global Eszopiclone Company, Product Type & Application
  7. 3.7 Global Eszopiclone Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Eszopiclone Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Eszopiclone Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Eszopiclone Tier 1, Tier 2, and Tier 3
4 Eszopiclone Regional Status and Outlook
  1. 4.1 Global Eszopiclone Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Eszopiclone Historic Market Size by Region
  3. 4.2.1 Global Eszopiclone Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Eszopiclone Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Eszopiclone Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Eszopiclone Forecasted Market Size by Region
  7. 4.3.1 Global Eszopiclone Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Eszopiclone Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Eszopiclone Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Eszopiclone by Application
  1. 5.1 Eszopiclone Market by Application
  2. 5.1.1 Tablet
  3. 5.1.2 Capsule
  4. 5.1.3 Other
  5. 5.2 Global Eszopiclone Market Size by Application
  6. 5.2.1 Global Eszopiclone Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Eszopiclone Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Eszopiclone Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Eszopiclone Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Eszopiclone Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Eszopiclone Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Eszopiclone Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Eszopiclone Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Tasly Pharmaceutical
  2. 6.1.1 Tasly Pharmaceutical Company Information
  3. 6.1.2 Tasly Pharmaceutical Business Overview
  4. 6.1.3 Tasly Pharmaceutical Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Tasly Pharmaceutical Eszopiclone Product Portfolio
  6. 6.1.5 Tasly Pharmaceutical Recent Developments
  7. 6.2 Sun Pharmaceutical
  8. 6.2.1 Sun Pharmaceutical Company Information
  9. 6.2.2 Sun Pharmaceutical Business Overview
  10. 6.2.3 Sun Pharmaceutical Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sun Pharmaceutical Eszopiclone Product Portfolio
  12. 6.2.5 Sun Pharmaceutical Recent Developments
  13. 6.3 Kanghong Pharmaceutical
  14. 6.3.1 Kanghong Pharmaceutical Company Information
  15. 6.3.2 Kanghong Pharmaceutical Business Overview
  16. 6.3.3 Kanghong Pharmaceutical Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Kanghong Pharmaceutical Eszopiclone Product Portfolio
  18. 6.3.5 Kanghong Pharmaceutical Recent Developments
  19. 6.4 Wockhardt
  20. 6.4.1 Wockhardt Company Information
  21. 6.4.2 Wockhardt Business Overview
  22. 6.4.3 Wockhardt Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Wockhardt Eszopiclone Product Portfolio
  24. 6.4.5 Wockhardt Recent Developments
  25. 6.5 Tapi Teva
  26. 6.5.1 Tapi Teva Company Information
  27. 6.5.2 Tapi Teva Business Overview
  28. 6.5.3 Tapi Teva Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Tapi Teva Eszopiclone Product Portfolio
  30. 6.5.5 Tapi Teva Recent Developments
  31. 6.6 Shanghai Pharmaceuticals Holding
  32. 6.6.1 Shanghai Pharmaceuticals Holding Company Information
  33. 6.6.2 Shanghai Pharmaceuticals Holding Business Overview
  34. 6.6.3 Shanghai Pharmaceuticals Holding Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shanghai Pharmaceuticals Holding Eszopiclone Product Portfolio
  36. 6.6.5 Shanghai Pharmaceuticals Holding Recent Developments
  37. 6.7 Kanghong Pharmaceutical
  38. 6.7.1 Kanghong Pharmaceutical Company Information
  39. 6.7.2 Kanghong Pharmaceutical Business Overview
  40. 6.7.3 Kanghong Pharmaceutical Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Kanghong Pharmaceutical Eszopiclone Product Portfolio
  42. 6.7.5 Kanghong Pharmaceutical Recent Developments
  43. 6.8 Glenmark Life Sciences
  44. 6.8.1 Glenmark Life Sciences Company Information
  45. 6.8.2 Glenmark Life Sciences Business Overview
  46. 6.8.3 Glenmark Life Sciences Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Glenmark Life Sciences Eszopiclone Product Portfolio
  48. 6.8.5 Glenmark Life Sciences Recent Developments
  49. 6.9 Dr. Reddy’s Laboratories
  50. 6.9.1 Dr. Reddy’s Laboratories Company Information
  51. 6.9.2 Dr. Reddy’s Laboratories Business Overview
  52. 6.9.3 Dr. Reddy’s Laboratories Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Dr. Reddy’s Laboratories Eszopiclone Product Portfolio
  54. 6.9.5 Dr. Reddy’s Laboratories Recent Developments
  55. 6.10 Centaur Pharmaceuticals
  56. 6.10.1 Centaur Pharmaceuticals Company Information
  57. 6.10.2 Centaur Pharmaceuticals Business Overview
  58. 6.10.3 Centaur Pharmaceuticals Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Centaur Pharmaceuticals Eszopiclone Product Portfolio
  60. 6.10.5 Centaur Pharmaceuticals Recent Developments
  61. 6.11 Admiron Life
  62. 6.11.1 Admiron Life Company Information
  63. 6.11.2 Admiron Life Business Overview
  64. 6.11.3 Admiron Life Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Admiron Life Eszopiclone Product Portfolio
  66. 6.11.5 Admiron Life Recent Developments
7 North America by Country
  1. 7.1 North America Eszopiclone Sales by Country
  2. 7.1.1 North America Eszopiclone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Eszopiclone Sales by Country (2021-2026)
  4. 7.1.3 North America Eszopiclone Sales Forecast by Country (2027-2032)
  5. 7.2 North America Eszopiclone Market Size by Country
  6. 7.2.1 North America Eszopiclone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Eszopiclone Market Size by Country (2021-2026)
  8. 7.2.3 North America Eszopiclone Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Eszopiclone Sales by Country
  2. 8.1.1 Europe Eszopiclone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Eszopiclone Sales by Country (2021-2026)
  4. 8.1.3 Europe Eszopiclone Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Eszopiclone Market Size by Country
  6. 8.2.1 Europe Eszopiclone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Eszopiclone Market Size by Country (2021-2026)
  8. 8.2.3 Europe Eszopiclone Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Eszopiclone Sales by Country
  2. 9.1.1 Asia-Pacific Eszopiclone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Eszopiclone Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Eszopiclone Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Eszopiclone Market Size by Country
  6. 9.2.1 Asia-Pacific Eszopiclone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Eszopiclone Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Eszopiclone Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Eszopiclone Sales by Country
  2. 10.1.1 South America Eszopiclone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Eszopiclone Sales by Country (2021-2026)
  4. 10.1.3 South America Eszopiclone Sales Forecast by Country (2027-2032)
  5. 10.2 South America Eszopiclone Market Size by Country
  6. 10.2.1 South America Eszopiclone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Eszopiclone Market Size by Country (2021-2026)
  8. 10.2.3 South America Eszopiclone Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Eszopiclone Sales by Country
  2. 11.1.1 Middle East and Africa Eszopiclone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Eszopiclone Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Eszopiclone Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Eszopiclone Market Size by Country
  6. 11.2.1 Middle East and Africa Eszopiclone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Eszopiclone Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Eszopiclone Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Eszopiclone Value Chain Analysis
  2. 12.1.1 Eszopiclone Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Eszopiclone Production Mode & Process
  7. 12.2 Eszopiclone Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Eszopiclone Distributors
  10. 12.2.3 Eszopiclone Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research